The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(1-(4-(1H-indol-1-yl)benzyl)-1H-pyrazol-3-yl)-N-hydroxypentanamide ID: ALA3335298
PubChem CID: 118714375
Max Phase: Preclinical
Molecular Formula: C23H24N4O2
Molecular Weight: 388.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCCCc1ccn(Cc2ccc(-n3ccc4ccccc43)cc2)n1)NO
Standard InChI: InChI=1S/C23H24N4O2/c28-23(25-29)8-4-2-6-20-14-15-26(24-20)17-18-9-11-21(12-10-18)27-16-13-19-5-1-3-7-22(19)27/h1,3,5,7,9-16,29H,2,4,6,8,17H2,(H,25,28)
Standard InChI Key: VUALYNHSKFMOKH-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
13.6674 -11.9223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4589 -11.7092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0372 -12.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8246 -12.0744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4311 -12.6222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0931 -11.3439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4583 -12.7097 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0367 -13.2880 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5349 -12.3717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8716 -12.8518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2083 -12.3717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4630 -11.5944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2802 -11.5944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3080 -12.6222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9186 -12.0744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7478 -11.2760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3543 -10.7281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1315 -10.9828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3022 -11.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6958 -12.3290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7380 -10.4349 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6539 -9.6245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4012 -9.2901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9449 -9.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7621 -9.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1707 -10.6057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7621 -11.3148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9449 -11.3148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5363 -10.6057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 6 2 0
1 7 1 0
7 8 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
9 13 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
21 29 1 0
24 29 2 0
18 21 1 0
9 14 1 0
5 11 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 388.47Molecular Weight (Monoisotopic): 388.1899AlogP: 4.09#Rotatable Bonds: 8Polar Surface Area: 72.08Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.91CX Basic pKa: 2.82CX LogP: 4.14CX LogD: 4.13Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.27Np Likeness Score: -1.21
References 1. Yao Y, Liao C, Li Z, Wang Z, Sun Q, Liu C, Yang Y, Tu Z, Jiang S.. (2014) Design, synthesis, and biological evaluation of 1, 3-disubstituted-pyrazole derivatives as new class I and IIb histone deacetylase inhibitors., 86 [PMID:25218912 ] [10.1016/j.ejmech.2014.09.024 ]